- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01333969
Ischemic Preconditioning in Total Knee Arthroplasty
December 23, 2024 updated by: Hospital for Special Surgery, New York
The Effect of Ischemic Preconditioning on Postoperative Pain After Total Knee Arthroplasty, a Randomized, Controlled Trial
The application of a tourniquet for 5 minutes and subsequent reperfusion before actual inflation of the tourniquet for total knee arthroplasty (ischemic preconditioning) decreases the level of local inflammation and therefore postoperative pain in response to reperfusion of the ischemic extremity.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
During knee surgery your surgeon routinely uses a device called a tourniquet that allows us to temporarily cut of blood supply to the site of surgery.
This helps to reduce blood loss and improves operating conditions.
When allowing blood back into your leg at the end of the procedure, debris (bone, fat, tissue breakdown products and cement from the surgery) gets washed out and gains access to the rest of your body.
In the vast majority of cases this event bares no major clinical consequences, but can rarely result in signs of inflammation of various body systems.
Patients with evidence of impaired organ system function such as pre-existing lung and heart disease may be more vulnerable.
Previous studies suggest that cutting off the blood supply for a short period of time just before a prolonged episode, could lead to a decrease in the extent of tissue breakdown products in this extremity and may thus be associated with a decrease in the inflammation of other organ systems.
We propose to study this theory in knee surgery patients by looking at levels of markers of inflammation present in the blood before and after surgery.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- Hospital For Special Surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- All patients undergoing primary total knee arthroplasty
Exclusion Criteria:
- Patients who chronically use narcotics (<1 month).
- Patients with contraindications (severe peripheral vascular disease, presence of femoral-popliteal bypass grafts, etc.) or no plan for tourniquet use as determined by the clinical care team.
- Patients who are on corticosteroids prior to their surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Ishcemic Preconditioning
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period.
Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components).
|
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period.
Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components).
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
|
|
No Intervention: Control
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Pain at Rest and Exercise as Assessed by Visual Analogue Scale (VAS) Scores at 48h After Surgery
Time Frame: 48hrs after surgery
|
Visual Analogue Scale (VAS) are used to measure the intensity of pain.
The total scale ranged from 0 (no pain) to 10 (excruciating pain).
The average value at POD 48hours was reported for each arm/group.
|
48hrs after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Epidural Volume
Time Frame: At 48hrs after surgery
|
Postoperative pain management included an epidural infusion of 10mcg/ml bupivacaine 0.06%/hydromorphone with a basal rate of 4 mL, a demand dose of 4 mL, and a lockout of 10 minutes.
Basal rates were reduced to 2 mL and 0 mL in the morning of postoperative Days 1 and 2, respectively and epidural catheters removed on postoperative Day 2. Overall epidural volume was the total volume given over 48 hours.
|
At 48hrs after surgery
|
|
Muscle Oxygenation Over Calf at 48h After Surgery
Time Frame: At 48 hrs after surgery
|
muscle tissue oxygenation was measured using a novel noninvasive near infrared spectroscopy device at baseline and at 48 hours postoperatively
|
At 48 hrs after surgery
|
|
Levels of Interleukin 6 (IL6) in Drainage Fluid at 24hr Postoperatively
Time Frame: At 24 hours postoperatively
|
At 24 hours postoperatively
|
|
|
Periarticular Circumference of the Knee at 6h, 24h, and 48h
Time Frame: measured at 6 hours, 24 hours, and 48 hours
|
Periarticular circumference of the knee as compared to contralateral side as crude marker of swelling at 6h, 24, and 48h postoperatively.
The data from the specified time points (6h, 24h, and 48h) were combined and the average value was reported for each arm/group.
|
measured at 6 hours, 24 hours, and 48 hours
|
|
Hospital Length of Stay
Time Frame: Up to discharge date
|
Up to discharge date
|
|
|
Physical Therapy Milestone
Time Frame: Up to discharge date
|
Amount of time until patients reached their physical therapy milestone (40 ft ambulation) during admission
|
Up to discharge date
|
|
Levels of Leukocytes in Drainage Fluid at 24hr Postoperatively
Time Frame: 24 hours postoperatively
|
24 hours postoperatively
|
|
|
Levels of TNF-alpha in Drainage Fluid at 24hr Postoperatively
Time Frame: 24 hours postoperatively
|
24 hours postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Stavros G. Memtsoudis, MD, PhD, Hospital for Special Surgery, New York
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (Actual)
April 1, 2012
Study Completion (Actual)
April 1, 2012
Study Registration Dates
First Submitted
April 11, 2011
First Submitted That Met QC Criteria
April 11, 2011
First Posted (Estimated)
April 12, 2011
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 23, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012-038
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Pain
-
National and Kapodistrian University of AthensCompletedPostoperative Pain, Acute | Postoperative Pain, Chronic | Postoperative Pain After Thoracic SurgeryGreece
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingPostoperative Pain | Postoperative Pain Management | Postoperative Pain in Orthopaedics
-
University of MalayaActive, not recruitingPostoperative Pain | Postoperative Pain ManagementMalaysia
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Bezmialem Vakif UniversityRecruitingPostoperative Pain ManagementTurkey
-
Pacira Pharmaceuticals, IncCompletedPostoperative Pain ManagementUnited States
-
Ain Shams UniversityCompletedPostoperative Pain Relief
Clinical Trials on Ischemic Preconditioning
-
Sun Yat-sen UniversityNot yet recruitingRenal Cell Carcinoma (RCC) | Renal Function AbnormalChina
-
Ulsan University HospitalCompletedContrast Induced Acute Kidney InjuryKorea, Republic of
-
Tartu University HospitalCompletedAtherosclerosis | Stable Angina | Peripheral Artery Disease | Contrast-induced NephropathyEstonia
-
Università Vita-Salute San RaffaeleActive, not recruitingMyocardial Ischemia | SurgerySingapore, Croatia, China, Italy, Switzerland, Kazakhstan, Serbia, Colombia, Russia
-
Jinling Hospital, ChinaRecruitingIschemic Stroke | Remote Ischaemic PreconditioningChina
-
Guangzhou Sport UniversityRecruitingMuscle Fatigue | Sports Recovery | Basketball Performance | Lower Extremity Explosive Power DeficitChina
-
St. Francis Hospital, New YorkTerminatedCoronary Artery DiseaseUnited States
-
Capital Medical UniversityPeking University First HospitalCompletedCerebral Small Vessel DiseaseChina
-
Azienda Ospedaliera Città della Salute e della...CompletedAcute Kidney InjurySpain, France, Italy
-
Second Affiliated Hospital of Nanchang UniversityNot yet recruitingCerebrovascular Disease | Depression Anxiety Disorder | Cerebral Apoplexy